Eddit

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 20: Zeile 20:
 
{{tp|p=32312715|t=2020. Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines |pdf=|usr=}}
 
{{tp|p=32312715|t=2020. Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines |pdf=|usr=}}
 
{{tp|p=32354810|t=2020. An alternative COVID-19 checklist |pdf=|usr=}}
 
{{tp|p=32354810|t=2020. An alternative COVID-19 checklist |pdf=|usr=}}
 
+
{{tp|p=32290887|t=ä. COVID-19: What paramedics need to know!|pdf=|usr=}}
  
 
*'''[[Respiration mgmt]]'''
 
*'''[[Respiration mgmt]]'''
Zeile 33: Zeile 33:
 
{{tp|p=32229575|t=2020. Covid-19: Mercedes F1 to provide breathing aid as alternative to ventilator |pdf=|usr=}}
 
{{tp|p=32229575|t=2020. Covid-19: Mercedes F1 to provide breathing aid as alternative to ventilator |pdf=|usr=}}
 
{{tp|p=32377387|t=2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19 |pdf=|usr=}}
 
{{tp|p=32377387|t=2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19 |pdf=|usr=}}
 +
{{tp|p=32346862|t=2020. Inhaled NO and COVID-19 |pdf=|usr=}}
 +
{{tp|p=32102726|t=2020. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019 |pdf=|usr=}}
 +
{{tp|p=32097201|t=2020. Non-invasive respiratory support for patients with novel coronavirus pneumonia: clinical efficacy and reduction in risk of infection transmission |pdf=|usr=}}
 +
{{tp|p=32369390|t=2020. Differentiating COVID-19 Pneumonia from Acute Respiratory Distress Syndrome (ARDS) and High Altitude Pulmonary Edema (HAPE): Therapeutic Implications |pdf=|usr=}}
  
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
Zeile 38: Zeile 42:
 
{{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}}
 
{{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}}
 
{{tp|p=32294808|t=2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology) |pdf=|usr=}}
 
{{tp|p=32294808|t=2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology) |pdf=|usr=}}
 +
{{tp|p=32367615|t=2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing |pdf=|usr=}}
 +
{{ttp|p=32187837|t=2020. Supersensitive Multifluorophore RNA-FISH for Early Virus Detection and Flow-FISH  by Using Click Chemistry |pdf=|usr=}}
 +
{{ttp|p=32221132|t=2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic  variation on published real-time quantitative polymerase chain reaction detection assays |pdf=|usr=}}
 +
{{tp|p=32149771|t=2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days |pdf=|usr=}}
 +
 +
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
Zeile 44: Zeile 54:
 
{{tp|p=32357307|t=2020. Radiographic examination of the chest and COVID-19 |pdf=|usr=}}
 
{{tp|p=32357307|t=2020. Radiographic examination of the chest and COVID-19 |pdf=|usr=}}
 
{{tp|p=32271603|t=2020. Dynamic Chest CT Evaluation in Three Cases of 2019 Novel Coronavirus Pneumonia |pdf=|usr=}}
 
{{tp|p=32271603|t=2020. Dynamic Chest CT Evaluation in Three Cases of 2019 Novel Coronavirus Pneumonia |pdf=|usr=}}
 
+
{{tp|p=32282404|t=2020. Incidental CT Findings Suspicious for COVID-19?Associated Pneumonia on Nuclear Medicine Examinations: Recognition and Management Plan |pdf=|usr=}}
  
  
Zeile 58: Zeile 68:
 
{{tp|p=32369402|t=2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2) |pdf=|usr=}}
 
{{tp|p=32369402|t=2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2) |pdf=|usr=}}
 
{{tp|p=32378705|t=2020. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity |pdf=|usr=}}
 
{{tp|p=32378705|t=2020. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity |pdf=|usr=}}
 +
{{tp|p=32132669|t=2020. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
 +
{{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
 +
  
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
Zeile 70: Zeile 83:
 
{{ttp|p=32376393|t=ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |pdf=|usr=}}
 
{{ttp|p=32376393|t=ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |pdf=|usr=}}
 
{{tp|p=32220633|t=2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?|pdf=|usr=}}
 
{{tp|p=32220633|t=2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?|pdf=|usr=}}
 +
{{tp|p=32297671|t=2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients |pdf=|usr=}}
 +
{{tp|p=32311762|t=2020. SARS-CoV-2: a new aetiology for atypical lymphocytes |pdf=|usr=}}
 +
{{tp|p=32297330|t=2020. Reactive lymphocytes in patients with Covid-19 |pdf=|usr=}}
 +
{{ttp|p=32203188|t=2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |pdf=|usr=}}
 +
{{ttp|p=32203186|t=2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
 +
{{ttp|p=32314313|t=2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}}
 +
{{tp|p=32375560|t=2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study |pdf=|usr=}}
 +
 +
  
  
Zeile 88: Zeile 110:
 
{{ttp|p=32323565|t=2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed  Severity of COVID-19?|pdf=|usr=}}
 
{{ttp|p=32323565|t=2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed  Severity of COVID-19?|pdf=|usr=}}
 
{{tp|p=32379894|t=2020. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia |pdf=|usr=}}
 
{{tp|p=32379894|t=2020. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia |pdf=|usr=}}
 
+
{{tp|p=32259373|t=2020. Cytologic and histologic samples from patients infected by the novel coronavirus  2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety procedures |pdf=|usr=}}
 
+
{{tp|p=32346073|t=2020. COVID-19: towards understanding of pathogenesis |pdf=|usr=}}
  
 
*'''[[Disease Models]]'''
 
*'''[[Disease Models]]'''
Zeile 111: Zeile 133:
 
{{tp|p=32271596|t=2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran |pdf=|usr=}}
 
{{tp|p=32271596|t=2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran |pdf=|usr=}}
 
{{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}}
 
{{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}}
 +
{{tp|p=32379863|t=ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |pdf=|usr=}}
 +
 +
  
 
*'''[[ARDS]]'''
 
*'''[[ARDS]]'''
Zeile 117: Zeile 142:
 
{{tp|p=32339221|t=2020. COVID-19 and its implications for thrombosis and anticoagulation |pdf=|usr=}}
 
{{tp|p=32339221|t=2020. COVID-19 and its implications for thrombosis and anticoagulation |pdf=|usr=}}
 
{{tp|p=32374029|t=2020. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis |pdf=|usr=}}
 
{{tp|p=32374029|t=2020. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis |pdf=|usr=}}
 
+
{{tp|p=32369614|t=2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in  a patient with COVID-19 and acute promyelocytic leukaemia |pdf=|usr=}}
 +
{{ttp|p=32369610|t=2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |pdf=|usr=}}
 +
{{tp|p=32353183|t=2020. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 |pdf=|usr=}}
 +
{{ttp|p=32330308|t=2020. COVID19 coagulopathy in Caucasian patients |pdf=|usr=}}
 +
{{ttp|p=32304581|t=2020. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis |pdf=|usr=}}
 +
{{tp|p=32304577|t=2020. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action |pdf=|usr=}}
 +
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
 +
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
  
 
*'''[[Hematology]]'''
 
*'''[[Hematology]]'''
 
{{tp|p=32369626|t=2020. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia |pdf=|usr=}}
 
{{tp|p=32369626|t=2020. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia |pdf=|usr=}}
 
{{tp|p=32374906|t=2020. Autoimmune haemolytic anaemia associated with COVID-19 infection |pdf=|usr=}}
 
{{tp|p=32374906|t=2020. Autoimmune haemolytic anaemia associated with COVID-19 infection |pdf=|usr=}}
 +
{{tp|p=32369609|t=2020. Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review |pdf=|usr=}}
 +
 +
  
 
*'''[[Heart]]'''
 
*'''[[Heart]]'''
Zeile 128: Zeile 163:
 
*'''[[Neurology, ophthalmology, orl]]'''
 
*'''[[Neurology, ophthalmology, orl]]'''
 
{{tp|p=32327427|t=2020. Myositis as a manifestation of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32327427|t=2020. Myositis as a manifestation of SARS-CoV-2 |pdf=|usr=}}
 
+
{{tp|p=32086236|t=2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear |pdf=|usr=}}
  
 
*'''[[Dermatology]]'''
 
*'''[[Dermatology]]'''
Zeile 139: Zeile 174:
 
{{tp|p=32374032|t=2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |pdf=|usr=}}
 
{{tp|p=32374032|t=2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |pdf=|usr=}}
 
{{tp|p=32302212|t=2020. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation |pdf=|usr=}}
 
{{tp|p=32302212|t=2020. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation |pdf=|usr=}}
 +
{{tp|p=32339257|t=2020. Acute pancreatitis in a COVID-19 patient |pdf=|usr=}}
 +
{{tp|p=32343396|t=2020. Covid-19 may present with acute abdominal pain |pdf=|usr=}}
 +
{{tp|p=32371168|t=ä. The Topic of COVID-19?Related Liver Injury Needs More Rigorous Research |pdf=|usr=}}
  
  
Zeile 176: Zeile 214:
 
{{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected  with SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected  with SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
 
{{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
 +
{{tp|p=32369606|t=2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience |pdf=|usr=}}
 +
{{tp|p=32314798|t=2020. COVID-19 infection in patients with sickle cell disease |pdf=|usr=}}
 +
{{tp|p=32333398|t=2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance |pdf=|usr=}}
 +
{{tp|p=32312714|t=2020. COVID-19 More Frequent, Severe in Cancer Patients |pdf=|usr=}}
 +
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
 +
{{tp|p=32302248|t=2020. ACEing COVID-19: A Role For Angiotensin Axis Inhibition in SARS-CoV-2 infection?|pdf=|usr=}}
 +
{{tp|p=32302265|t=2020. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension  Hospitalized With COVID-19 |pdf=|usr=}}
  
 
+
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
  
 
*'''[[The morbid survivor]]'''
 
*'''[[The morbid survivor]]'''
 
{{tp|p=32364491|t=ä. Are COVID-19 survivors at increased risk for suicide?|pdf=|usr=}}
 
{{tp|p=32364491|t=ä. Are COVID-19 survivors at increased risk for suicide?|pdf=|usr=}}
 
{{tp|p=32282359|t=2020. Rehabilitation After Critical Illness in People With COVID-19 Infection |pdf=|usr=}}
 
{{tp|p=32282359|t=2020. Rehabilitation After Critical Illness in People With COVID-19 Infection |pdf=|usr=}}
 +
{{tp|p=32251003|t=2020. Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis |pdf=|usr=}}
 +
{{tp|p=32251002|t=2020. Recommendations for respiratory rehabilitation in adults with COVID-19 |pdf=|usr=}}
 +
  
  
Zeile 194: Zeile 242:
 
*'''[[Case series]]'''
 
*'''[[Case series]]'''
 
{{tp|p=32255382|t=2020. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China |pdf=|usr=}}
 
{{tp|p=32255382|t=2020. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China |pdf=|usr=}}
 
+
{{tp|p=32360780|t=ä. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19 |pdf=|usr=}}
  
  
  
 
*'''[[Registries]]'''
 
*'''[[Registries]]'''
 +
{{tp|p=32298145|t=2020. Role of Data Registries in the Time of COVID-19 |pdf=|usr=}}
 +
{{tp|p=32364764|t=2020. Data quarantine in the time of the COVID-19 pandemic |pdf=|usr=}}
 +
 +
 
----
 
----
  
Zeile 245: Zeile 297:
 
{{tp|p=32304110|t=2020. Dosing will be a key success factor in repurposing antivirals for COVID-19 |pdf=|usr=}}
 
{{tp|p=32304110|t=2020. Dosing will be a key success factor in repurposing antivirals for COVID-19 |pdf=|usr=}}
 
{{ttp|p=32369628|t=2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date |pdf=|usr=}}
 
{{ttp|p=32369628|t=2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date |pdf=|usr=}}
 +
{{tp|p=32369612|t=2020. Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma |pdf=|usr=}}
 +
{{tp|p=32368792|t=2020. Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2 |pdf=|usr=}}
 +
{{ttp|p=32358833|t=2020. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development  IUPHAR Review 29 |pdf=|usr=}}
 +
{{tp|p=32329520|t=2020. Current pharmacological treatments for COVID-19: What s next?|pdf=|usr=}}
 +
{{tp|p=32371479|t=2020. Cytokine Storm Drugs Move from CAR T to COVID-19 |pdf=|usr=}}
 +
{{tp|p=32303509|t=2020. Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32276929|t=2020. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?|pdf=|usr=}}
 +
{{ttp|p=32324951|t=2020. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics |pdf=|usr=}}
 +
{{tp|p=32245590|t=2020. Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP) |pdf=|usr=}}
 +
 +
 +
 
----
 
----
  
Zeile 281: Zeile 345:
 
{{tp|p=32345601|t=2020. Covid-19 makes the future of UK clinical research uncertain |pdf=|usr=}}
 
{{tp|p=32345601|t=2020. Covid-19 makes the future of UK clinical research uncertain |pdf=|usr=}}
 
{{tp|p=32340996|t=2020. Managing patients with rheumatic conditions during the covid-19 pandemic |pdf=|usr=}}
 
{{tp|p=32340996|t=2020. Managing patients with rheumatic conditions during the covid-19 pandemic |pdf=|usr=}}
 
+
{{tp|p=32330288|t=2020. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32259402|t=2020. Biosafety in the preparation and processing of cytology specimens with potential  coronavirus (COVID-19) infection: Perspectives from Taiwan |pdf=|usr=}}
 +
{{tp|p=32379342|t=2020. Clearing the air: an accessible system for suction and safe evacuation of pneumoperitoneum during laparoscopy in patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32363596|t=2020. Safe management of surgical smoke in the age of COVID-19 |pdf=|usr=}}
 +
{{tp|p=32259400|t=2020. Going remote: Maintaining normalcy in our pathology laboratories during the COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32259387|t=2020. International perspectives: Impact of the COVID-19 pandemic on cytology |pdf=|usr=}}
 +
{{tp|p=32238358|t=2020. Clinical Research Slows as COVID-19 Surges |pdf=|usr=}}
 +
{{tp|p=32209598|t=2020. COVID-19 Challenges Basic Researchers |pdf=|usr=}}
 +
{{tp|p=32332087|t=2020. COVID-19 Hits Cancer Research Funding |pdf=|usr=}}
 +
{{tp|p=32311816|t=2020. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American  College of Emergency Physicians (ACEP) |pdf=|usr=}}
 +
{{tp|p=32348003|t=2020. The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic |pdf=|usr=}}
 +
{{tp|p=32348003|t=2020. The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic |pdf=|usr=}}
 +
{{tp|p=32252979|t=2020. Manejo quirurgico de pacientes con infeccion por COVID-19  Recomendaciones de la  Asociacion Espanola de Cirujanos |pdf=|usr=}}
 +
{{tp|p=32367794|t=ä. Recommendations for emergency departments receiving patients with vital signs absent from paramedics during COVID-19 |pdf=|usr=}}
 +
{{tp|p=32327003|t=ä. Just the Facts: Protected code blue ? Cardiopulmonary resuscitation in the emergency department during the coronavirus disease 2019 pandemic |pdf=|usr=}}
 +
{{tp|p=32360779|t=ä. Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting |pdf=|usr=}}
  
  
 
*'''[[Mental aspects of health professionals]]'''
 
*'''[[Mental aspects of health professionals]]'''
 
+
{{tp|p=32205120|t=2020. Traumatization in medical staff helping with COVID-19 control |pdf=|usr=}}
  
  
Zeile 382: Zeile 461:
 
{{tp|p=32317248|t=2020. Covid-19: doctors are warned not to go public about PPE shortages |pdf=|usr=}}
 
{{tp|p=32317248|t=2020. Covid-19: doctors are warned not to go public about PPE shortages |pdf=|usr=}}
 
{{tp|p=32299810|t=2020. Covid-19: Coronavirus was first described in The BMJ in 1965 |pdf=|usr=}}
 
{{tp|p=32299810|t=2020. Covid-19: Coronavirus was first described in The BMJ in 1965 |pdf=|usr=}}
 +
{{tp|p=32235915|t=2020. COVID-19: a new challenge for human beings |pdf=|usr=}}
 +
 +
  
 
*'''[[misc.]]'''
 
*'''[[misc.]]'''

Version vom 31. Mai 2020, 16:07 Uhr


32327431 2020. Keeping up with studies on covid-19: systematic search strategies and resources



32202343 ä. Systematic review of COVID?19 in children shows milder cases and a better prognosis than adults
32196678 ä. Eleven faces of coronavirus disease 2019
32363707 2020. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review
32253003 2020. COVID-19 virus and children: What do we know?
32303495 2020. Clinical features of covid-19



32279352 2020. Blood and blood product use during COVID-19 infection
32223716 2020. Diagnosis and Management of COVID-19 Disease
32221973 2020. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice
32189015 2020. "Coronavirus disease 2019" (COVID-19): update fur Anasthesisten und Intensivmediziner Marz 2020
32312715 2020. Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines
32354810 2020. An alternative COVID-19 checklist
32290887 ä. COVID-19: What paramedics need to know!

32330073 2020. COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications


32319081 2020. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?

32358233 2020. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers


32341294 2020. Toward Precision Delivery of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Cardiorespiratory Failure
32317557 2020. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients
32243267 2020. Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure
32243266 2020. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China
32366375 2020. Management of respiratory failure due to covid-19
32229575 2020. Covid-19: Mercedes F1 to provide breathing aid as alternative to ventilator
32377387 2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19
32346862 2020. Inhaled NO and COVID-19
32102726 2020. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019
32097201 2020. Non-invasive respiratory support for patients with novel coronavirus pneumonia: clinical efficacy and reduction in risk of infection transmission
32369390 2020. Differentiating COVID-19 Pneumonia from Acute Respiratory Distress Syndrome (ARDS) and High Altitude Pulmonary Edema (HAPE): Therapeutic Implications


32293905 2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients
32338536 2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR)
32294808 2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology)
32367615 2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing

32187837 2020. Supersensitive Multifluorophore RNA-FISH for Early Virus Detection and Flow-FISH by Using Click Chemistry
32221132 2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays


32149771 2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days



32275766 2020. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review
32298464 2020. Whole body point-care ultrasound for COVID-19: a multi-system approach to a multi-system disease
32357307 2020. Radiographic examination of the chest and COVID-19
32271603 2020. Dynamic Chest CT Evaluation in Three Cases of 2019 Novel Coronavirus Pneumonia
32282404 2020. Incidental CT Findings Suspicious for COVID-19?Associated Pneumonia on Nuclear Medicine Examinations: Recognition and Management Plan





32348474 2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle


32369402 2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2)
32378705 2020. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity
32132669 2020. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
32149770 2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction



32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms


32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32311762 2020. SARS-CoV-2: a new aetiology for atypical lymphocytes
32297330 2020. Reactive lymphocytes in patients with Covid-19

32203188 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
32203186 2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
32314313 2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?


32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study



32376400 ä. Cytokine storm syndrome in severe COVID-19
32376401 ä. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?


32293098 2020. On the Alert for Cytokine Storm: Immunopathology in COVID-19
32339387 2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
32345602 2020. Covid-19: concerns grow over inflammatory syndrome emerging in children




32379417 ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

32376402 ä. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
32361194 ä. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
32323565 2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?


32379894 2020. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia
32259373 2020. Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety procedures
32346073 2020. COVID-19: towards understanding of pathogenesis


32348692 2020. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
32374218 2020. Avian coronaviruses





32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic
32271596 2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran

32374823 2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak


32379863 ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization



32339221 2020. COVID-19 and its implications for thrombosis and anticoagulation
32374029 2020. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis
32369614 2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia

32369610 2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily


32353183 2020. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19

32330308 2020. COVID19 coagulopathy in Caucasian patients
32304581 2020. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis


32304577 2020. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend


32369626 2020. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia
32374906 2020. Autoimmune haemolytic anaemia associated with COVID-19 infection
32369609 2020. Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review



32255359 2020. Clinical utility of cardiac troponin measurement in COVID-19 infection


32327427 2020. Myositis as a manifestation of SARS-CoV-2
32086236 2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear


32353170 2020. Cutaneous lesions in a patient with COVID-19: are they related?
32348545 2020. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases



32374032 2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors
32302212 2020. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation
32339257 2020. Acute pancreatitis in a COVID-19 patient
32343396 2020. Covid-19 may present with acute abdominal pain
32371168 ä. The Topic of COVID-19?Related Liver Injury Needs More Rigorous Research



32376320 ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract
32320102 ä. Hydatidiform mole in the era of COVID?19 pandemic Is there an association?
32266828 2020. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)



32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32241792 2020. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
32354772 2020. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
32332075 2020. Patients with lupus are not protected from COVID-19
32332072 2020. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
32295789 2020. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
32327426 2020. SLE patients are not immune to covid-19: importance of sending the right message across
32295787 2020. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32312768 2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
32245656 2020. COVID-19 in patients with cardiovascular diseases
32180426 2020. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes
32255510 2020. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
32369656 2020. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding
32219995 2020. Safe delivery for pregnancies affected by COVID-19
32339382 2020. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis
32324956 2020. How should we treat pregnant women infected with SARS-CoV-2?
32340018 2020. Coronavirus Disease 2019 in a Hemodialysis Patient
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32241880 2020. Drugs and the renin-angiotensin system in covid-19
32291262 2020. Covid-19: Black people and other minorities are hardest hit in US
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease
32333398 2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance
32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32302248 2020. ACEing COVID-19: A Role For Angiotensin Axis Inhibition in SARS-CoV-2 infection?
32302265 2020. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19


32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend


32364491 ä. Are COVID-19 survivors at increased risk for suicide?
32282359 2020. Rehabilitation After Critical Illness in People With COVID-19 Infection
32251003 2020. Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis
32251002 2020. Recommendations for respiratory rehabilitation in adults with COVID-19



32277694 2020. Case Report: Death Due to Novel Coronavirus Disease (COVID-19) in Three Brothers
32375200 2020. Pneumomediastinum following intubation in COVID-19 patients: a case series
32304394 2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report
32371416 2020. Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection



32255382 2020. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China
32360780 ä. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19



32298145 2020. Role of Data Registries in the Time of COVID-19
32364764 2020. Data quarantine in the time of the COVID-19 pandemic





32245769 2020. Managing clinical trials for covid-19: the importance of ethics committees



32329159 2020. Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach
32376597 2020. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
32345616 2020. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
32304395 2020. COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support

32349115 ä. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19


32380318 ä. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
32380316 ä. Convalescent plasma in Covid-19: Possible mechanisms of action
32380315 ä. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32376396 ä. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
32376395 ä. SARS-CoV-2 infection among patients with systemic autoimmune diseases

32376392 ä. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions


32376403 ä. Imatinib might constitute a treatment option for lung involvement in COVID-19

32376394 ä. Immunomodulatory therapy for the management of severe COVID-19 Beyond the anti-viral therapy: A comprehensive review
32376397 ä. Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view


32376398 ä. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
32361195 ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
32304139 ä. Progress and Concept for COVID?19 Vaccine Development
32213152 2020. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
32299796 2020. Antirheumatic agents in covid-19: is IL-6 the right target?

32376613 2020. Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor Alisporivir (Debio 025)


32366720 2020. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
32312781 2020. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
32205349 2020. Updated Approaches against SARS-CoV-2
32229155 2020. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
32339387 2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
32282033 2020. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
32362106 2020. Management of conjunctivitis during the COVID-19 pandemic 2020
32302379 2020. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
32366511 2020. Developing a vaccine for covid-19
32357949 2020. Covid-19: Remdesivir is helpful but not a wonder drug, say researchers
32217607 2020. Covid-19: what treatments are being investigated?
32217555 2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
32209549 2020. Covid-19: trials of four potential treatments to generate "robust data" of what works
32340998 2020. Covid-19: What do we know so far about a vaccine?
32321732 2020. Remdesivir in covid-19
32359080 2020. Off-target ACE2 ligands: Possible therapeutic option for CoVid-19?
32304110 2020. Dosing will be a key success factor in repurposing antivirals for COVID-19

32369628 2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date


32369612 2020. Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma
32368792 2020. Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2

32358833 2020. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development IUPHAR Review 29


32329520 2020. Current pharmacological treatments for COVID-19: What s next?
32371479 2020. Cytokine Storm Drugs Move from CAR T to COVID-19
32303509 2020. Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19
32276929 2020. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?

32324951 2020. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics


32245590 2020. Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)





32189463 ä. The possibility of COVID?19 transmission from eye to nose
32189460 ä. There may be virus in conjunctival secretion of patients with COVID?19




32352852 2020. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from Filtered Face Piece (FFP) masks during the coronavirus (COVID-19) pandemic
32366499 2020. Covid-19: skin damage with prolonged wear of FFP3 masks

32371574 2020. Facial protection for healthcare workers during pandemics: a scoping review



32311772 2020. Intubation boxes for managing the airway in patients with COVID-19

32311771 2020. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review


32324055 2020. A safe method to evacuate pneumoperitoneum during laparoscopic surgery in suspected COVID-19 patients
32380058 ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership

32379080 2020. Protecting Surgical Teams During the COVID-19 Outbreak: A Narrative Review and Clinical Considerations


32345617 2020. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
32345619 2020. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
32219857 ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases
32376399 ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
32376346 ä. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions
32369287 2020. COVID-19: GENERAL GUIDELINES FOR CARDIOVASCULAR SURGEONS (standard guidelines - subject to change)
32223063 ä. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab?specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID?19
32361152 ä. The Use of Bronchoscopy During the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report
32253182 2020. Social distancing in covid-19: what are the mental health implications?
32345601 2020. Covid-19 makes the future of UK clinical research uncertain
32340996 2020. Managing patients with rheumatic conditions during the covid-19 pandemic
32330288 2020. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic
32259402 2020. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan
32379342 2020. Clearing the air: an accessible system for suction and safe evacuation of pneumoperitoneum during laparoscopy in patients with COVID-19
32363596 2020. Safe management of surgical smoke in the age of COVID-19
32259400 2020. Going remote: Maintaining normalcy in our pathology laboratories during the COVID-19 pandemic
32259387 2020. International perspectives: Impact of the COVID-19 pandemic on cytology
32238358 2020. Clinical Research Slows as COVID-19 Surges
32209598 2020. COVID-19 Challenges Basic Researchers
32332087 2020. COVID-19 Hits Cancer Research Funding
32311816 2020. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)
32348003 2020. The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic
32348003 2020. The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic
32252979 2020. Manejo quirurgico de pacientes con infeccion por COVID-19 Recomendaciones de la Asociacion Espanola de Cirujanos
32367794 ä. Recommendations for emergency departments receiving patients with vital signs absent from paramedics during COVID-19
32327003 ä. Just the Facts: Protected code blue ? Cardiopulmonary resuscitation in the emergency department during the coronavirus disease 2019 pandemic
32360779 ä. Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting



32205120 2020. Traumatization in medical staff helping with COVID-19 control





32376695 2020. Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020


32366503 2020. Covid-19: NHS bosses told to assess risk to ethnic minority staff who may be at greater risk


32366510 2020. Covid-19: collateral damage of lockdown in India
32253178 2020. Covid-19 and the rise of racism





32196426 2020. Seasonality of Respiratory Viral Infections




32298494 2020. The role of children in the transmission of mild SARS-CoV-2 infection
32369541 ä. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review
32267964 2020. Infection control in non-clinical areas during the COVID-19 pandemic
32271600 2020. Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review
32371381 2020. Covid-19: South Korea relaxes social distancing after the number of new cases drops below 10 a day
32376669 2020. Reducing risks from coronavirus transmission in the home-the role of viral load
32366374 2020. Covid-19: Deprived areas have the highest death rates in England and Wales
32217520 2020. The world s largest refugee camp prepares for covid-19
32205334 2020. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village
32205309 2020. Covid-19: Highest risk patients are asked to stay at home for 12 weeks
32209548 2020. Covid-19: UK lockdown is "crucial" to saving lives, say doctors and scientists
32184206 2020. Covid-19: Doctors warn of humanitarian catastrophe at Europe s largest refugee camp
32265194 2020. Covid-19: Why Germany s case fatality rate seems so low
32368995 ä. Mental health and COVID-19: is the virus racist?
32345590 2020. Covid-19: undocumented migrants are probably at greatest risk
32312785 2020. Is ethnicity linked to incidence or outcomes of covid-19?
32241884 2020. Covid-19: four fifths of cases are asymptomatic, China figures indicate



32366742 ä. Prolonged Viral RNA Shedding Duration in COVID-19
32342849 2020. Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19)



32324421 2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health
32366370 2020. Covid-19: Coroners needn t investigate PPE policy failures in deaths of NHS staff, new guidance says



32358933 2020. Lessons from the USA Delayed Response to the COVID-19 Pandemic
32144176 2020. Trump claims public health warnings on covid-19 are a conspiracy against him
32224494 2020. Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest
32205354 2020. Clinical trials suspended in UK to prioritise covid-19 studies and free up staff
32107254 2020. Covid-19: Trump says risk to Americans is "very low"
32321703 2020. The Brazilian slums hiring their own doctors to fight covid-19




32227594 ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic
32213480 2020. Covid-19: how to be careful with trust and expertise on social media





32271601 2020. Epidemiology and Clinical Characteristics of COVID-19
32144096 2020. Covid-19: UK records first death, as world s cases exceed 100 000
32165426 2020. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction
32071063 2020. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
32273278 2020. Covid-19: should the public wear face masks?
32273267 2020. Face masks for the public during the covid-19 crisis
32265341 2020. Covid-19: What is the evidence for cloth masks?
32354787 2020. A third of covid-19 patients admitted to UK hospitals die
32327412 2020. Covid-19: Two thirds of healthcare workers who have died were from ethnic minorities
32317248 2020. Covid-19: doctors are warned not to go public about PPE shortages
32299810 2020. Covid-19: Coronavirus was first described in The BMJ in 1965
32235915 2020. COVID-19: a new challenge for human beings



32220929 2020. Guidance needed for singlehanded GPs to deal with covid-19 pandemic
32205317 2020. Covid-19: give NHS staff rest spaces and free parking not thank yous, says doctor
32349824 ä. The COVID-19 Pandemic: A Month of Bioethics in Finland
32327407 2020. Covid-19: BMA demands full death in service benefits for UK doctors
32317305 2020. Covid-19: increasing demand for dialysis sparks fears of supply shortage
32354814 2020. Viewpoint: COVID-19 This virus is not the real enemy, but our approach to it could be


Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis